|
Recent Newsletters
Why some COVID-19 patients should stop taking blood pressure medications | CMR imaging & COVID-related heart damage |
Weekend Edition: Coronary CTA recommendations | Heart damage from COVID-19 improves over time | Statin spending |
Heart Failure: Older patients & COVID-related heart damage | Hydroxychloroquine & azithromycin | Empagliflozin |
Why COVID-19 could be a microvascular disease—and what that means for treatment | Stem cells & heart damage |
Experts recommend coronary CTA for stable CAD—but one team offers a warning | Treating MIS-C | Big news for Medtronic |
Healthcare Economics & Policy: Salary updates for cardiologists | Cannabis & CV health | A new proposal from CMS |
Heart damage from COVID-19 may improve over time | Endocarditis after TAVR | A new tool for cardiac care |